Back­ground

ISAR Bioscience is a trans­la­tional com­pany devel­op­ing tech­no­lo­gies and new ther­apies for degen­er­at­ive dis­eases. We work closely with pub­lic research insti­tu­tions and com­pan­ies from the bio­tech­no­logy and phar­ma­ceut­ical indus­tries. We aim to build bridges between these insti­tu­tions and thus cre­ate a dir­ect link between basic research and new ther­apies and products. This is what we mean when we speak of “trans­la­tion”.

The dis­eases that we tar­get are all char­ac­ter­ized by a patho­lo­gical loss of organ func­tion – due to age­ing, insuf­fi­cient blood cir­cu­la­tion or a mal­func­tion­ing immune sys­tem. Examples are Alzheimer’s dis­ease and chronic car­diac fail­ure, which often occurs after a sur­viv­ing heart attack.
In these degen­er­at­ive dis­eases the nat­ural abil­ity of the organs to regen­er­ate from their own stem cells is no longer suf­fi­cient. This leads to the loss of cells and finally to the loss of organ function.
Such dis­eases play a major role world­wide. In most soci­et­ies they rep­res­ent the greatest bur­den of dis­ease, they are respons­ible for most hos­pital admis­sions and are the most fre­quent causes of death. If degen­er­at­ive dis­eases can be pushed back, the vis­ion of healthy age­ing comes within reach.